Liquid Biopsy Market 2019 Industry Trends, Size, Share, Growth Insight, Leading Players, Competitive, Regional Analysis With Forecast To 2022
Oct 1, 2019
The Liquid Biopsy Market research report of Market Research Future comprises of extensive primary research with detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market.
Pune, India - September 30, 2019 /MarketersMedia/ —
Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart.
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/710
Segmentation:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.
Major Players
The major players in the global liquid biopsy market are Guardant Health, Inc. (US), Trovagene, Inc. (California), RainDance Technologies, Inc. (US), Agena Bioscience Inc. (California), Admera Health (US), Biocept, Inc. KGaA (US), Circulogene Theranostics (Alabama), Inivata Ltd (UK), SAGA Diagnostics AB (Sweden), and Exosome Diagnostics (Massachusetts).
Some of the key strategies followed by the players operating in the global liquid biopsy market are adopting various strategies to expand their global liquid biopsy business and enhance their market share.
Drivers
The market drivers for the liquid biopsy market are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Also the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Regional Analysis:
Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.
Key findings
• Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.
• On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
• The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period
Browse 171 Pages Premium Research Report with List of Tables and Figures at @ https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
Key Updates
• In January 2017, Guardant Health, Inc. and MD Anderson announced their partnership to make comprehensive liquid biopsy part of oncology standard of care.
• In April 2016, Agena Bioscience, Inc. launched high sensitivity and multiplexed genetic testing product for targeted analysis of solid tumors. iPLEX HS chemistry enables detection of genetic variants, including somatic mutations, translocations, and indels, that are present at levels as low as 1% in frequency.
• In January 2016, Inivita Ltd raised USD 31.5 million in a Series A fundraising from existing investors such as Imperial Innovations, Cambridge Innovation Capital, and Johnson & Johnson Innovation - JJDC, Inc. The new investor was Woodford Patient Capital Trust.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
Source: MarketersMedia
Release ID: 88924226
More News
China’s new nightmare: a Japanese containment arc in the Indo-Pacific
Just weeks after US President Donald Trump and Chinese President Xi Jinping invoked their countries’ World War II alliance at the White House, Keen Sword 27 turned symbolism into hardware. The 11-day exercise, which wrapped up on October 29, deployed US Marine NMESIS anti-ship launchers and MADIS air-defence systems to Yonaguni – Japan’s westernmost island, just 110km (70 miles) from Taiwan. Japan mobilised its new Type 25 missile, with a reported 1,000km range, from Kumamoto for the system’s...
Afghan Woman Is Among Dozens to Be Deported to Afghanistan
The Trump administration has arranged a flight to send dozens of Afghan immigrants back to Afghanistan, despite the risk of persecution by the Taliban.
Australian Court Hears Challenge to Social Media Ban
Reddit and an Australian digital advocacy group are claiming a law that restricts children younger than 16 from popular platforms infringes on their constitutional rights.
The China-Pakistan Information Corridor Is Made to Silence Journalists
CPIC arrives in a country where the words "fake news" can already put a reporter in prison.
How China Is Building Influence in Central Asia, One Laboratory at a Time
Scientific and educational cooperation may be less visible than a railway, but it may also have longer lasting and broader results.
Indonesian police arrest 3 for tapping Prabowo’s phone
Indonesian authorities have arrested three people for allegedly tapping President Prabowo Subianto’s phone, according to police on Tuesday, with media reports suggesting one of the suspects may be a senior official. Prabowo, who took office in 2024, has come under increasing pressure for his government’s handling of the economy and destructive wildfires in the Southeast Asian archipelago. Top detective Asep Safrudin identified the suspects only by their initials, LSP, ASN, and EH, and said they...
Amid Stock Troubles, Is South Korea’s $880 Billion AI Infrastructure Buildout Under Threat?
South Korea has emerged as one of the world leaders in the AI buildout. But now, as investor sell-offs continue to force the KOSPI lower, are its AI ambitions under threat?
Decouple Taiwan From China-Vatican Negotiations
Archbishop Gallagher’s remarks about the “price” of setting up an office in Beijing have struck a nerve in Taiwan. But the two aren’t actually related.
Indian navy frees hijacked Iranian fishing crew off Somalia
Indian naval forces freed an Iranian fishing boat and its crew of 20 hijacked off Somalia after an operation lasting more than 48 hours, India’s Defence Ministry said on Tuesday. The rescue of the Azini was completed on Monday in the Arabian Sea, more than 3,000km (1,860 miles) from Mumbai, Indian Defence Minister Rajnath Singh said. An official with the Puntland Maritime Police Force said Indian forces disarmed 12 suspected Somali pirates, confiscated their mobile phones and released them. He...
Does Reliance on China Undermine Iran’s Grand Strategy?
China’s interests in the Middle East increasingly conflict with Iran’s cooperation with regional proxies and use of coercive threats.
German tourist missing in Indonesia’s Bali after landslide amid rainy season
A German tourist was among two men still missing on Tuesday after a landslide struck a glamping resort on the island of Bali in Indonesia. Heavy rains on Sunday afternoon caused the landslide, which struck the Eco Park Pelaga Glamping Retreat in Petang district at around 11pm, The Bali Times reported. Three tents collapsed while a fourth fell into the Tukad Yeh Kilap River and was swept away by the currents. The 4-hectare (10-acre) property, which houses 25 tents, sits on a steep cliff beside...
Why Chinese AI stars like Z.ai, MiniMax struggle to match Anthropic’s profit margin
US artificial intelligence giant Anthropic’s initial public offering prospectus has exposed a vast profitability gap between it and rivals Z.ai and MiniMax, highlighting the challenges facing China’s AI model developers in turning technological advances into sustainable businesses. The Claude developer’s filing with the US Securities and Exchange Commission (SEC) last week revealed a significant financial advantage over its most direct Chinese counterparts, despite the latter’s continued...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.